KH-01501 series

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKH-01501 series
Drug Alias Nameatherogenic enzyme inhibitors (Abbott)atherogenic enzyme inhibitors (Kos Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKos Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesKos Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A